nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—Hepatic pain—Topotecan—cervical cancer	0.213	0.325	CcSEcCtD
Trabectedin—Mucosal inflammation—Topotecan—cervical cancer	0.0321	0.0489	CcSEcCtD
Trabectedin—SRC—GP1b-IX-V activation signalling—GP5—cervical cancer	0.03	0.118	CbGpPWpGaD
Trabectedin—Febrile neutropenia—Topotecan—cervical cancer	0.0295	0.045	CcSEcCtD
Trabectedin—Extravasation—Topotecan—cervical cancer	0.0203	0.031	CcSEcCtD
Trabectedin—Hyperbilirubinaemia—Topotecan—cervical cancer	0.0195	0.0298	CcSEcCtD
Trabectedin—Pulmonary embolism—Topotecan—cervical cancer	0.0177	0.0271	CcSEcCtD
Trabectedin—Sepsis—Topotecan—cervical cancer	0.0154	0.0235	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.0116	0.0177	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Topotecan—cervical cancer	0.0114	0.0173	CcSEcCtD
Trabectedin—Pancytopenia—Topotecan—cervical cancer	0.0106	0.0161	CcSEcCtD
Trabectedin—SRC—Platelet Aggregation (Plug Formation)—GP5—cervical cancer	0.0105	0.0414	CbGpPWpGaD
Trabectedin—Neutropenia—Topotecan—cervical cancer	0.0104	0.0159	CcSEcCtD
Trabectedin—Infestation NOS—Topotecan—cervical cancer	0.00993	0.0151	CcSEcCtD
Trabectedin—Infestation—Topotecan—cervical cancer	0.00993	0.0151	CcSEcCtD
Trabectedin—Stomatitis—Topotecan—cervical cancer	0.00968	0.0148	CcSEcCtD
Trabectedin—Hepatobiliary disease—Topotecan—cervical cancer	0.00939	0.0143	CcSEcCtD
Trabectedin—Haemoglobin—Topotecan—cervical cancer	0.00896	0.0137	CcSEcCtD
Trabectedin—Haemorrhage—Topotecan—cervical cancer	0.00891	0.0136	CcSEcCtD
Trabectedin—SRC—Interleukin-11 Signaling Pathway—PIAS3—cervical cancer	0.00828	0.0326	CbGpPWpGaD
Trabectedin—Angiopathy—Topotecan—cervical cancer	0.00808	0.0123	CcSEcCtD
Trabectedin—Mediastinal disorder—Topotecan—cervical cancer	0.00803	0.0122	CcSEcCtD
Trabectedin—SRC—epithelium—cervical cancer	0.008	0.0888	CbGeAlD
Trabectedin—SRC—uterine cervix—cervical cancer	0.00793	0.0881	CbGeAlD
Trabectedin—Alopecia—Topotecan—cervical cancer	0.00787	0.012	CcSEcCtD
Trabectedin—Malnutrition—Topotecan—cervical cancer	0.00776	0.0118	CcSEcCtD
Trabectedin—SRC—decidua—cervical cancer	0.00755	0.0839	CbGeAlD
Trabectedin—Back pain—Topotecan—cervical cancer	0.0075	0.0114	CcSEcCtD
Trabectedin—SRC—renal system—cervical cancer	0.00742	0.0824	CbGeAlD
Trabectedin—Anaemia—Topotecan—cervical cancer	0.00717	0.0109	CcSEcCtD
Trabectedin—Leukopenia—Topotecan—cervical cancer	0.00694	0.0106	CcSEcCtD
Trabectedin—Cough—Topotecan—cervical cancer	0.00677	0.0103	CcSEcCtD
Trabectedin—Arthralgia—Topotecan—cervical cancer	0.0066	0.0101	CcSEcCtD
Trabectedin—Myalgia—Topotecan—cervical cancer	0.0066	0.0101	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00656	0.01	CcSEcCtD
Trabectedin—Infection—Topotecan—cervical cancer	0.00629	0.00959	CcSEcCtD
Trabectedin—Nervous system disorder—Topotecan—cervical cancer	0.00621	0.00947	CcSEcCtD
Trabectedin—Thrombocytopenia—Topotecan—cervical cancer	0.0062	0.00945	CcSEcCtD
Trabectedin—Skin disorder—Topotecan—cervical cancer	0.00615	0.00938	CcSEcCtD
Trabectedin—SRC—Oncostatin M Signaling Pathway—PIAS3—cervical cancer	0.00606	0.0239	CbGpPWpGaD
Trabectedin—Anorexia—Topotecan—cervical cancer	0.00603	0.0092	CcSEcCtD
Trabectedin—SRC—female reproductive system—cervical cancer	0.00594	0.066	CbGeAlD
Trabectedin—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—cervical cancer	0.00581	0.0229	CbGpPWpGaD
Trabectedin—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00577	0.00879	CcSEcCtD
Trabectedin—Paraesthesia—Topotecan—cervical cancer	0.00568	0.00867	CcSEcCtD
Trabectedin—Dyspnoea—Topotecan—cervical cancer	0.00564	0.00861	CcSEcCtD
Trabectedin—Dyspepsia—Topotecan—cervical cancer	0.00557	0.0085	CcSEcCtD
Trabectedin—Decreased appetite—Topotecan—cervical cancer	0.0055	0.00839	CcSEcCtD
Trabectedin—SRC—Cell surface interactions at the vascular wall—GP6—cervical cancer	0.00548	0.0216	CbGpPWpGaD
Trabectedin—Gastrointestinal disorder—Topotecan—cervical cancer	0.00547	0.00833	CcSEcCtD
Trabectedin—Fatigue—Topotecan—cervical cancer	0.00546	0.00832	CcSEcCtD
Trabectedin—Constipation—Topotecan—cervical cancer	0.00541	0.00825	CcSEcCtD
Trabectedin—SRC—female gonad—cervical cancer	0.00541	0.06	CbGeAlD
Trabectedin—Gastrointestinal pain—Topotecan—cervical cancer	0.00518	0.00789	CcSEcCtD
Trabectedin—Body temperature increased—Topotecan—cervical cancer	0.005	0.00763	CcSEcCtD
Trabectedin—Abdominal pain—Topotecan—cervical cancer	0.005	0.00763	CcSEcCtD
Trabectedin—SRC—Androgen receptor signaling pathway—PIAS3—cervical cancer	0.00472	0.0186	CbGpPWpGaD
Trabectedin—Hypersensitivity—Topotecan—cervical cancer	0.00466	0.00711	CcSEcCtD
Trabectedin—Asthenia—Topotecan—cervical cancer	0.00454	0.00693	CcSEcCtD
Trabectedin—Diarrhoea—Topotecan—cervical cancer	0.00433	0.0066	CcSEcCtD
Trabectedin—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.0042	0.0165	CbGpPWpGaD
Trabectedin—Dizziness—Topotecan—cervical cancer	0.00419	0.00638	CcSEcCtD
Trabectedin—CYP2E1—Tryptophan metabolism—UBE3A—cervical cancer	0.00405	0.0159	CbGpPWpGaD
Trabectedin—Vomiting—Topotecan—cervical cancer	0.00403	0.00614	CcSEcCtD
Trabectedin—Rash—Topotecan—cervical cancer	0.00399	0.00609	CcSEcCtD
Trabectedin—Dermatitis—Topotecan—cervical cancer	0.00399	0.00608	CcSEcCtD
Trabectedin—Headache—Topotecan—cervical cancer	0.00397	0.00605	CcSEcCtD
Trabectedin—Nausea—Topotecan—cervical cancer	0.00376	0.00573	CcSEcCtD
Trabectedin—CYP2E1—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.00348	0.0137	CbGpPWpGaD
Trabectedin—SRC—lymph node—cervical cancer	0.00347	0.0386	CbGeAlD
Trabectedin—SRC—Syndecan-3-mediated signaling events—FGFR3—cervical cancer	0.00343	0.0135	CbGpPWpGaD
Trabectedin—SRC—Androgen receptor signaling pathway—UBE3A—cervical cancer	0.00304	0.012	CbGpPWpGaD
Trabectedin—PTGS1—epithelium—cervical cancer	0.00298	0.0331	CbGeAlD
Trabectedin—PTGS1—uterine cervix—cervical cancer	0.00296	0.0329	CbGeAlD
Trabectedin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00296	0.0116	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—PIAS3—cervical cancer	0.00292	0.0115	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.00288	0.0113	CbGpPWpGaD
Trabectedin—CYP2E1—renal system—cervical cancer	0.00287	0.0319	CbGeAlD
Trabectedin—CYP2C19—vagina—cervical cancer	0.00283	0.0315	CbGeAlD
Trabectedin—PTGS1—renal system—cervical cancer	0.00277	0.0307	CbGeAlD
Trabectedin—PTGS1—endometrium—cervical cancer	0.00268	0.0297	CbGeAlD
Trabectedin—PTGS1—mammalian vulva—cervical cancer	0.00259	0.0288	CbGeAlD
Trabectedin—SRC—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.00252	0.00991	CbGpPWpGaD
Trabectedin—PTGS1—uterus—cervical cancer	0.00247	0.0274	CbGeAlD
Trabectedin—CYP2C9—female reproductive system—cervical cancer	0.00243	0.027	CbGeAlD
Trabectedin—CYP3A4—renal system—cervical cancer	0.00231	0.0257	CbGeAlD
Trabectedin—CYP2E1—female reproductive system—cervical cancer	0.0023	0.0256	CbGeAlD
Trabectedin—SRC—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.00228	0.00898	CbGpPWpGaD
Trabectedin—CYP2D6—renal system—cervical cancer	0.00228	0.0253	CbGeAlD
Trabectedin—SRC—Costimulation by the CD28 family—HLA-DPB1—cervical cancer	0.00225	0.00886	CbGpPWpGaD
Trabectedin—SRC—Syndecan-2-mediated signaling events—FGFR3—cervical cancer	0.00223	0.00878	CbGpPWpGaD
Trabectedin—SRC—Notch Signaling Pathway—NOTCH2—cervical cancer	0.00222	0.00874	CbGpPWpGaD
Trabectedin—PTGS1—female reproductive system—cervical cancer	0.00222	0.0246	CbGeAlD
Trabectedin—SRC—E-cadherin signaling in keratinocytes—CTNNB1—cervical cancer	0.00214	0.00843	CbGpPWpGaD
Trabectedin—SRC—Negative regulation of FGFR signaling—FGFR3—cervical cancer	0.00205	0.00807	CbGpPWpGaD
Trabectedin—PTGS1—female gonad—cervical cancer	0.00202	0.0224	CbGeAlD
Trabectedin—PTGS1—vagina—cervical cancer	0.00201	0.0223	CbGeAlD
Trabectedin—SRC—FSH signaling pathway—MTOR—cervical cancer	0.00198	0.00778	CbGpPWpGaD
Trabectedin—SRC—FAS (CD95) signaling pathway—CASP8—cervical cancer	0.00195	0.00768	CbGpPWpGaD
Trabectedin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00195	0.00767	CbGpPWpGaD
Trabectedin—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.00188	0.00739	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—INSM1—cervical cancer	0.00186	0.00731	CbGpPWpGaD
Trabectedin—CYP3A4—female reproductive system—cervical cancer	0.00185	0.0206	CbGeAlD
Trabectedin—CYP2D6—female reproductive system—cervical cancer	0.00182	0.0202	CbGeAlD
Trabectedin—SRC—Notch Signaling Pathway—HES1—cervical cancer	0.00182	0.00716	CbGpPWpGaD
Trabectedin—SRC—Costimulation by the CD28 family—HLA-DQB1—cervical cancer	0.00176	0.00691	CbGpPWpGaD
Trabectedin—SRC—CD28 co-stimulation—MTOR—cervical cancer	0.00172	0.00679	CbGpPWpGaD
Trabectedin—SRC—E-cadherin signaling in keratinocytes—EGFR—cervical cancer	0.0017	0.00668	CbGpPWpGaD
Trabectedin—SRC—Syndecan-3-mediated signaling events—EGFR—cervical cancer	0.0017	0.00668	CbGpPWpGaD
Trabectedin—SRC—Alpha 6 Beta 4 signaling pathway—MTOR—cervical cancer	0.00168	0.00663	CbGpPWpGaD
Trabectedin—CYP2D6—female gonad—cervical cancer	0.00166	0.0184	CbGeAlD
Trabectedin—SRC—FGF signaling pathway—FGFR3—cervical cancer	0.00161	0.00635	CbGpPWpGaD
Trabectedin—SRC—Nectin adhesion pathway—CTNNB1—cervical cancer	0.00161	0.00634	CbGpPWpGaD
Trabectedin—SRC—Class I PI3K signaling events mediated by Akt—MTOR—cervical cancer	0.00161	0.00632	CbGpPWpGaD
Trabectedin—SRC—EPO Receptor Signaling—STAT3—cervical cancer	0.00157	0.0062	CbGpPWpGaD
Trabectedin—SRC—CXCR3-mediated signaling events—MTOR—cervical cancer	0.0015	0.00592	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—SERPIND1—cervical cancer	0.00149	0.00585	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—GP6—cervical cancer	0.00149	0.00585	CbGpPWpGaD
Trabectedin—SRC—FAS (CD95) signaling pathway—CASP3—cervical cancer	0.00148	0.00581	CbGpPWpGaD
Trabectedin—SRC—Syndecan-2-mediated signaling events—CASP3—cervical cancer	0.00144	0.00568	CbGpPWpGaD
Trabectedin—SRC—ErbB2/ErbB3 signaling events—MTOR—cervical cancer	0.00141	0.00557	CbGpPWpGaD
Trabectedin—SRC—E-cadherin signaling in the nascent adherens junction—CTNNB1—cervical cancer	0.00139	0.00548	CbGpPWpGaD
Trabectedin—SRC—Notch Signaling Pathway—NOTCH1—cervical cancer	0.00137	0.00541	CbGpPWpGaD
Trabectedin—SRC—Nanoparticle-mediated activation of receptor signaling—EGFR—cervical cancer	0.00135	0.00531	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00134	0.00529	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—GP5—cervical cancer	0.0013	0.00511	CbGpPWpGaD
Trabectedin—PTGS1—lymph node—cervical cancer	0.0013	0.0144	CbGeAlD
Trabectedin—SRC—Signaling of Hepatocyte Growth Factor Receptor—STAT3—cervical cancer	0.00127	0.005	CbGpPWpGaD
Trabectedin—SRC—TSLP Signaling Pathway—MTOR—cervical cancer	0.00127	0.00499	CbGpPWpGaD
Trabectedin—PTGS1—Selenium Micronutrient Network—MTHFR—cervical cancer	0.00125	0.00494	CbGpPWpGaD
Trabectedin—SRC—Integrins in angiogenesis—CASP8—cervical cancer	0.00122	0.0048	CbGpPWpGaD
Trabectedin—SRC—AGE/RAGE pathway—CASP8—cervical cancer	0.00117	0.00463	CbGpPWpGaD
Trabectedin—SRC—Posttranslational regulation of adherens junction stability and dissassembly—CASP3—cervical cancer	0.00115	0.00452	CbGpPWpGaD
Trabectedin—SRC—PDGF Pathway—STAT3—cervical cancer	0.00114	0.00448	CbGpPWpGaD
Trabectedin—SRC—ErbB Signaling Pathway—MTOR—cervical cancer	0.00113	0.00447	CbGpPWpGaD
Trabectedin—SRC—Arf6 signaling events—EGFR—cervical cancer	0.00113	0.00444	CbGpPWpGaD
Trabectedin—SRC—RANKL/RANK Signaling Pathway—MTOR—cervical cancer	0.00112	0.0044	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by TCPTP—STAT3—cervical cancer	0.00112	0.00439	CbGpPWpGaD
Trabectedin—SRC—Posttranslational regulation of adherens junction stability and dissassembly—CTNNB1—cervical cancer	0.00111	0.00435	CbGpPWpGaD
Trabectedin—SRC—ErbB2/ErbB3 signaling events—STAT3—cervical cancer	0.00109	0.0043	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—AKAP13—cervical cancer	0.00106	0.00419	CbGpPWpGaD
Trabectedin—SRC—Internalization of ErbB1—EGFR—cervical cancer	0.00106	0.00416	CbGpPWpGaD
Trabectedin—SRC—Interleukin-11 Signaling Pathway—STAT3—cervical cancer	0.00103	0.00407	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by TCPTP—EGFR—cervical cancer	0.00101	0.00399	CbGpPWpGaD
Trabectedin—SRC—TSLP Signaling Pathway—STAT3—cervical cancer	0.00098	0.00386	CbGpPWpGaD
Trabectedin—SRC—Oncostatin M Signaling Pathway—MTOR—cervical cancer	0.000979	0.00385	CbGpPWpGaD
Trabectedin—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—cervical cancer	0.000975	0.00384	CbGpPWpGaD
Trabectedin—SRC—GAB1 signalosome—FGFR3—cervical cancer	0.00097	0.00382	CbGpPWpGaD
Trabectedin—SRC—TSH signaling pathway—MTOR—cervical cancer	0.000967	0.00381	CbGpPWpGaD
Trabectedin—SRC—IL-3 Signaling Pathway—STAT3—cervical cancer	0.000948	0.00373	CbGpPWpGaD
Trabectedin—SRC—Costimulation by the CD28 family—MTOR—cervical cancer	0.000944	0.00372	CbGpPWpGaD
Trabectedin—SRC—Costimulation by the CD28 family—CD4—cervical cancer	0.000942	0.00371	CbGpPWpGaD
Trabectedin—SRC—CDC42 signaling events—MTOR—cervical cancer	0.000922	0.00363	CbGpPWpGaD
Trabectedin—SRC—LPA receptor mediated events—CASP3—cervical cancer	0.000911	0.00359	CbGpPWpGaD
Trabectedin—SRC—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000906	0.00357	CbGpPWpGaD
Trabectedin—SRC—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000906	0.00357	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by PTP1B—STAT3—cervical cancer	0.000904	0.00356	CbGpPWpGaD
Trabectedin—SRC—Oncostatin M Signaling Pathway—CASP3—cervical cancer	0.0009	0.00354	CbGpPWpGaD
Trabectedin—SRC—AGE/RAGE pathway—CASP3—cervical cancer	0.000889	0.0035	CbGpPWpGaD
Trabectedin—SRC—FGF signaling pathway—STAT3—cervical cancer	0.000877	0.00345	CbGpPWpGaD
Trabectedin—SRC—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—cervical cancer	0.000876	0.00345	CbGpPWpGaD
Trabectedin—SRC—Leptin signaling pathway—MTOR—cervical cancer	0.000873	0.00344	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—TERT—cervical cancer	0.00086	0.00339	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—cervical cancer	0.000847	0.00333	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—cervical cancer	0.000837	0.00329	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—MTOR—cervical cancer	0.000829	0.00326	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by PTP1B—EGFR—cervical cancer	0.000822	0.00323	CbGpPWpGaD
Trabectedin—SRC—CDC42 signaling events—CTNNB1—cervical cancer	0.000818	0.00322	CbGpPWpGaD
Trabectedin—SRC—Kit receptor signaling pathway—STAT3—cervical cancer	0.000817	0.00322	CbGpPWpGaD
Trabectedin—SRC—ErbB Signaling Pathway—EGFR—cervical cancer	0.000797	0.00314	CbGpPWpGaD
Trabectedin—SRC—CXCR4-mediated signaling events—MTOR—cervical cancer	0.000797	0.00314	CbGpPWpGaD
Trabectedin—SRC—Notch Signaling Pathway—STAT3—cervical cancer	0.000796	0.00313	CbGpPWpGaD
Trabectedin—SRC—CXCR4-mediated signaling events—CD4—cervical cancer	0.000796	0.00313	CbGpPWpGaD
Trabectedin—SRC—Thromboxane A2 receptor signaling—EGFR—cervical cancer	0.000774	0.00305	CbGpPWpGaD
Trabectedin—SRC—Oncostatin M Signaling Pathway—STAT3—cervical cancer	0.000756	0.00298	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—FGFR3—cervical cancer	0.000749	0.00295	CbGpPWpGaD
Trabectedin—SRC—TSH signaling pathway—STAT3—cervical cancer	0.000747	0.00294	CbGpPWpGaD
Trabectedin—SRC—AGE/RAGE pathway—STAT3—cervical cancer	0.000747	0.00294	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—STAT3—cervical cancer	0.000738	0.00291	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—CTNNB1—cervical cancer	0.000735	0.00289	CbGpPWpGaD
Trabectedin—SRC—LPA receptor mediated events—EGFR—cervical cancer	0.000696	0.00274	CbGpPWpGaD
Trabectedin—SRC—GAB1 signalosome—MTOR—cervical cancer	0.000682	0.00269	CbGpPWpGaD
Trabectedin—SRC—AGE/RAGE pathway—EGFR—cervical cancer	0.000679	0.00267	CbGpPWpGaD
Trabectedin—SRC—Androgen receptor signaling pathway—CTNNB1—cervical cancer	0.000675	0.00266	CbGpPWpGaD
Trabectedin—SRC—Leptin signaling pathway—STAT3—cervical cancer	0.000674	0.00265	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—FGFR3—cervical cancer	0.000673	0.00265	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—EGFR—cervical cancer	0.000671	0.00264	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—FGFR3—cervical cancer	0.00067	0.00264	CbGpPWpGaD
Trabectedin—SRC—ErbB Signaling Pathway—TP53—cervical cancer	0.000669	0.00263	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—MTOR—cervical cancer	0.000667	0.00262	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—MTOR—cervical cancer	0.000667	0.00262	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—FGFR3—cervical cancer	0.000667	0.00262	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—MTOR—cervical cancer	0.000657	0.00259	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—UBE3A—cervical cancer	0.000654	0.00257	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—FGFR3—cervical cancer	0.000624	0.00246	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—MTOR—cervical cancer	0.00062	0.00244	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—FGFR3—cervical cancer	0.000619	0.00243	CbGpPWpGaD
Trabectedin—SRC—CXCR4-mediated signaling events—STAT3—cervical cancer	0.000616	0.00242	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—FGFR3—cervical cancer	0.000613	0.00241	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—FGFR3—cervical cancer	0.00061	0.0024	CbGpPWpGaD
Trabectedin—SRC—Androgen receptor signaling pathway—STAT3—cervical cancer	0.000588	0.00232	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—CTNNB1—cervical cancer	0.000582	0.00229	CbGpPWpGaD
Trabectedin—SRC—Oncostatin M Signaling Pathway—TP53—cervical cancer	0.000577	0.00227	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—EGFR—cervical cancer	0.000571	0.00225	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—TP53—cervical cancer	0.000563	0.00222	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—FGFR3—cervical cancer	0.000553	0.00218	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—CTNNB1—cervical cancer	0.00055	0.00216	CbGpPWpGaD
Trabectedin—SRC—Androgen receptor signaling pathway—EGFR—cervical cancer	0.000535	0.0021	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—MTOR—cervical cancer	0.000527	0.00207	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—MTOR—cervical cancer	0.000518	0.00204	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—STAT3—cervical cancer	0.000515	0.00203	CbGpPWpGaD
Trabectedin—SRC—L1CAM interactions—EGFR—cervical cancer	0.000503	0.00198	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000502	0.00198	CbGpPWpGaD
Trabectedin—SRC—Cell-Cell communication—CTNNB1—cervical cancer	0.000498	0.00196	CbGpPWpGaD
Trabectedin—SRC—GAB1 signalosome—EGFR—cervical cancer	0.000479	0.00189	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—TP53—cervical cancer	0.000479	0.00189	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—CASP3—cervical cancer	0.000476	0.00187	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—MTOR—cervical cancer	0.000474	0.00186	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—MTOR—cervical cancer	0.000471	0.00186	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—MTOR—cervical cancer	0.000471	0.00186	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—MTOR—cervical cancer	0.000469	0.00185	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—EGFR—cervical cancer	0.000468	0.00184	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—CTNNB1—cervical cancer	0.000459	0.00181	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—STAT3—cervical cancer	0.000448	0.00176	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—MTOR—cervical cancer	0.000439	0.00173	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—MTOR—cervical cancer	0.000435	0.00171	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—MTOR—cervical cancer	0.000431	0.0017	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—MTOR—cervical cancer	0.000429	0.00169	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—FGFR3—cervical cancer	0.000425	0.00167	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—STAT3—cervical cancer	0.000407	0.0016	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—STAT3—cervical cancer	0.0004	0.00158	CbGpPWpGaD
Trabectedin—SRC—Immune System—UBE3A—cervical cancer	0.000397	0.00156	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—TP53—cervical cancer	0.000393	0.00155	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HLA-DPB1—cervical cancer	0.000391	0.00154	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—MTOR—cervical cancer	0.000389	0.00153	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.00038	0.0015	CbGpPWpGaD
Trabectedin—SRC—Disease—WNT2—cervical cancer	0.000372	0.00146	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—EGFR—cervical cancer	0.00037	0.00146	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—CTNNB1—cervical cancer	0.000368	0.00145	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000366	0.00144	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—STAT3—cervical cancer	0.000366	0.00144	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—STAT3—cervical cancer	0.000364	0.00143	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—HES1—cervical cancer	0.000341	0.00134	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—STAT3—cervical cancer	0.000339	0.00134	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TAAR6—cervical cancer	0.000334	0.00131	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—EGFR—cervical cancer	0.000333	0.00131	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—STAT3—cervical cancer	0.000332	0.00131	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—EGFR—cervical cancer	0.000331	0.0013	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—EGFR—cervical cancer	0.000331	0.0013	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—EGFR—cervical cancer	0.000329	0.0013	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—TP53—cervical cancer	0.000327	0.00129	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CA9—cervical cancer	0.000309	0.00122	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—EGFR—cervical cancer	0.000308	0.00121	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—EGFR—cervical cancer	0.000306	0.0012	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HLA-DQB1—cervical cancer	0.000305	0.0012	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—EGFR—cervical cancer	0.000303	0.00119	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—EGFR—cervical cancer	0.000302	0.00119	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—STAT3—cervical cancer	0.000301	0.00118	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—MTOR—cervical cancer	0.000299	0.00118	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—EGFR—cervical cancer	0.000291	0.00115	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.00029	0.00114	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CD8A—cervical cancer	0.000285	0.00112	CbGpPWpGaD
Trabectedin—SRC—Disease—WNT5A—cervical cancer	0.000282	0.00111	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—CASP3—cervical cancer	0.000275	0.00108	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—EGFR—cervical cancer	0.000273	0.00108	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—WNT2—cervical cancer	0.00026	0.00102	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—NOTCH1—cervical cancer	0.000258	0.00101	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000244	0.000959	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—FGFR3—cervical cancer	0.000242	0.000955	CbGpPWpGaD
Trabectedin—SRC—Immune System—HLA-DPB1—cervical cancer	0.000237	0.000932	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—FGFR3—cervical cancer	0.000233	0.000917	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—STAT3—cervical cancer	0.000231	0.00091	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CA9—cervical cancer	0.000231	0.000909	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AKAP13—cervical cancer	0.000229	0.0009	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—EGFR—cervical cancer	0.00021	0.000827	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CASP8—cervical cancer	0.000207	0.000816	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—WNT5A—cervical cancer	0.000197	0.000777	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—EGFR—cervical cancer	0.00019	0.000748	CbGpPWpGaD
Trabectedin—SRC—Immune System—HLA-DQB1—cervical cancer	0.000185	0.000728	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CA9—cervical cancer	0.000178	0.000702	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD8A—cervical cancer	0.000173	0.00068	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—CTNNB1—cervical cancer	0.000171	0.000674	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—MTOR—cervical cancer	0.000171	0.000672	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CD4—cervical cancer	0.00017	0.00067	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CA9—cervical cancer	0.000164	0.000645	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—MTOR—cervical cancer	0.000164	0.000645	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CD4—cervical cancer	0.000164	0.000644	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CA9—cervical cancer	0.000163	0.00064	CbGpPWpGaD
Trabectedin—SRC—Disease—HES1—cervical cancer	0.000162	0.000638	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CTNNB1—cervical cancer	0.000151	0.000595	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—STAT3—cervical cancer	0.000149	0.000588	CbGpPWpGaD
Trabectedin—SRC—Disease—MTHFR—cervical cancer	0.000142	0.000561	CbGpPWpGaD
Trabectedin—SRC—Disease—TERT—cervical cancer	0.000142	0.000559	CbGpPWpGaD
Trabectedin—SRC—Immune System—FGFR3—cervical cancer	0.000141	0.000556	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NOTCH2—cervical cancer	0.000139	0.000545	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—EGFR—cervical cancer	0.000136	0.000534	CbGpPWpGaD
Trabectedin—SRC—Disease—FGFR3—cervical cancer	0.00013	0.000513	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—MTHFR—cervical cancer	0.000125	0.000494	CbGpPWpGaD
Trabectedin—SRC—Disease—NOTCH1—cervical cancer	0.000122	0.000482	CbGpPWpGaD
Trabectedin—SRC—Immune System—CASP8—cervical cancer	0.000121	0.000475	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—EGFR—cervical cancer	0.00012	0.000472	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—EGFR—cervical cancer	0.000115	0.000453	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HES1—cervical cancer	0.000114	0.000447	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TP53—cervical cancer	0.000112	0.00044	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CA9—cervical cancer	0.000107	0.000422	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TERT—cervical cancer	9.95e-05	0.000392	CbGpPWpGaD
Trabectedin—SRC—Immune System—MTOR—cervical cancer	9.94e-05	0.000391	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD4—cervical cancer	9.92e-05	0.00039	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—MTHFR—cervical cancer	9.38e-05	0.000369	CbGpPWpGaD
Trabectedin—SRC—Disease—MTOR—cervical cancer	9.17e-05	0.000361	CbGpPWpGaD
Trabectedin—SRC—Disease—CD4—cervical cancer	9.16e-05	0.00036	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—FGFR3—cervical cancer	9.13e-05	0.000359	CbGpPWpGaD
Trabectedin—SRC—Immune System—CTNNB1—cervical cancer	8.81e-05	0.000347	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NOTCH1—cervical cancer	8.57e-05	0.000337	CbGpPWpGaD
Trabectedin—SRC—Disease—CTNNB1—cervical cancer	8.13e-05	0.00032	CbGpPWpGaD
Trabectedin—SRC—Immune System—STAT3—cervical cancer	7.68e-05	0.000302	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—MTHFR—cervical cancer	7.23e-05	0.000285	CbGpPWpGaD
Trabectedin—SRC—Disease—STAT3—cervical cancer	7.09e-05	0.000279	CbGpPWpGaD
Trabectedin—SRC—Immune System—EGFR—cervical cancer	6.98e-05	0.000275	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—MTHFR—cervical cancer	6.65e-05	0.000262	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—MTHFR—cervical cancer	6.6e-05	0.00026	CbGpPWpGaD
Trabectedin—SRC—Disease—EGFR—cervical cancer	6.44e-05	0.000254	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MTOR—cervical cancer	6.42e-05	0.000253	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CASP3—cervical cancer	5.91e-05	0.000233	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CTNNB1—cervical cancer	5.7e-05	0.000224	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—STAT3—cervical cancer	4.96e-05	0.000195	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EGFR—cervical cancer	4.51e-05	0.000178	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—MTHFR—cervical cancer	4.35e-05	0.000171	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TP53—cervical cancer	3.79e-05	0.000149	CbGpPWpGaD
